(Q54101103)

English

NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity.

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10102692

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10102692

title

NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10102692

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10102692

author name string

O'Harte FP

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10102692

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10102692

Mooney MH

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10102692

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10102692

Flatt PR

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10102692

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10102692

language of work or name

English

0 references

publication date

1 April 1999

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10102692

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10102692

published in

Diabetes

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10102692

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10102692

volume

48

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10102692

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10102692

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10102692

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10102692

page(s)

758-765

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10102692

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10102692

Identifiers

DOI

10.2337/DIABETES.48.4.758

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10102692

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10102692

PubMed publication ID

10102692

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10102692

retrieved

24 May 2018

reference URL

http://europepmc.org/abstract/MED/10102692

ResearchGate publication ID

13187964

0 references

(Q54101103)

NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)